Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Triple-negative breast cancer, or TNBC, is one of the most aggressive and difficult to treat forms of breast cancer.In recent years, scientists have developed a new treatment method that may revolutionize the therapies used against this particularly difficult type of cancer.
What is triple negative breast cancer?
Triple-negative breast cancer is a form of cancer that is characterized by the absence of estrogen receptor (ER), progesterone receptor (PR), and lack of expression of the HER2 receptor.This configuration of cancer cells makes traditional hormonal therapies and drugs directed against the HER2 receptor ineffective in the case of TNBC.
What has the treatment for tnbc been like so far?
Previous treatments for triple-negative breast cancer included mainly chemotherapy, which, unfortunately, often led to numerous side effects and did not always bring the expected results.The lack of specific molecular targets hampered effective therapy, leaving TNBC patients with limited treatment options.
What is egfr and why do scientists target this element?
EGFR, or epidermal growth factor receptors, have become a target of interest for scientists dealing with triple-negative breast cancer.Studies have shown that some patients with TNBC overexpress EGFR on the surface of tumor cells.This discovery became the starting point for the development of new therapies directed directly against these receptors.
Your suggestions
A new method of treating triple-negative breast cancer opens new perspectives for patients suffering from this form of cancer.However, as with any innovative therapy, it is important to monitor the progress of clinical trials and consult a doctor to adapt the therapy to the patient’s individual needs.
Recommended articles
If you are interested in the topic of triple negative breast cancer and the latest achievements in the field of oncology, we recommend reading the following articles:
A new method of treating triple-negative breast cancer gives hope for more effective and less invasive therapies for patients suffering from this difficult-to-fight form of breast cancer.Ongoing research and development in this field of medicine remains crucial to improving treatment outcomes and increasing the chances of a full recovery.